CSIMarket Company Name, Ticker, Competitors, else..
 
Arya Sciences Acquisition Corp Iv  (NASDAQ: ARYD)
Other Ticker:  
 
    Sector • Financial    Industry • Blank Checks
   Industry • Blank Checks
   Sector • Financial
 
Price: $6.6400 $-2.32 -25.893%
Day's High: $8.75 Week Perf: -37.83 %
Day's Low: $ 6.25 30 Day Perf: -42.01 %
Volume (M): 91 52 Wk High: $ 11.57
Volume (M$): $ 607 52 Wk Avg: $11.17
Open: $8.75 52 Wk Low: $6.25



 Market Capitalization (Millions $) 27
 Shares Outstanding (Millions) 4
 Employees -
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -3
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 0

Arya Sciences Acquisition Corp Iv
Arya Sciences Acquisition Corp IV is a special purpose acquisition company (SPAC) formed for the purpose of acquiring or merging with one or more businesses. It was founded by Perceptive Advisors, a leading healthcare-focused investment firm. As a SPAC, Arya Sciences Acquisition Corp IV primarily focuses on identifying and completing a merger or acquisition transaction in the healthcare or life sciences sector. The company aims to leverage its industry expertise and network to identify attractive investment opportunities that have the potential for significant growth and value creation.


   Company Address: 51 Astor Place, 10th Floor New York 10003 NY
   Company Phone Number: 284-2300   Stock Exchange / Ticker: NASDAQ ARYD


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Arya Sciences Acquisition Corp Iv

Arya Sciences Acquisition Corp IV Soars in First Quarter Earnings Report

As a financial journalist for the CSIMarket.com, I have been closely following the latest earnings results from the Blank Checks industry, specifically Arya Sciences Acquisition Corp Iv (ARYD). The first quarter of 2024 has brought both positive and concerning news for investors.
One key takeaway from the financial report is the operating loss of $-0.61174 million for Arya Sciences Acquisition Corp Iv. While this may seem like a significant loss, it is actually an improvement from the previous year's operating loss of $-0.968597 million in the first quarter of 2023. This improvement is a positive sign for investors, indicating that the company is making progress towards profitability.
Arya Sciences Acquisition Corp Iv

Blank Checks Company ARYD Faces Significant Operating Shortfall in Q4 2023: Struggles to Find Sustainable Revenue Streams

ARYD's Operating Shortfall Widens in Q4 2023 According to the latest financial reports for the reporting cycle from October to December 31, 2023, many businesses have disclosed their earnings. Among them are several companies in the Blank Checks industry. One such company, ARYD, reported an operating shortfall of $-2.745151 million for the fiscal period ending on December 31, 2023. This figure reveals the financial performance of the organization at its current level.
Comparing this operating shortfall to the same period in the previous year, the fourth quarter of 2022 recorded a shortfall of $-0.271136 million. This signifies a considerable increase in operating losses over the course of a year. ARYD has been exploring various business models to establish reliable and consistent revenue sources, but it appears they are still in the search for a successful strategy.
Arya Sciences Acquisition Corp Iv

Arya Sciences Acquisition Corp IV Reports Significant Operating Shortfall in Third Quarter of 2023

During the past 5 trading days, Arya Sciences Acquisition Corp IV stock has experienced a slight increase of 0.09%. This brings its year-to-date performance to 7.52%. Additionally, the stock has reached its 52-week high. These developments have drawn attention to the blank checks industry, where a few overlooked companies are now reporting their earnings.
One such company is ARYD. In the third quarter of 2023, ARYD reported an operating shortfall of $-0.959673 million. This marks a significant increase from the operating shortfall of $-0.180405 million reported in the third quarter of 2022.
Arya Sciences Acquisition Corp Iv

Arya Sciences Acquisition Corp IV Shows Promising Financial Turnaround with Fiscal Second Quarter Results


Introduction
The stock market is always abuzz with developments, especially in industries such as Blank Checks. While the big players often hog the limelight, it's fascinating to delve into the lesser-known corporations and explore their earnings. Arya Sciences Acquisition Corp Iv has recently reported its second-quarter earnings for 2023, and the results are certainly noteworthy.
Improving Finances
Arya Sciences Acquisition Corp Iv reported an operating shortfall of $-0.078851 million in the second quarter of 2023. In comparison, the second quarter of 2022 witnessed a higher operating shortfall of $-0.304811 million. This significant improvement in financial performance signals a positive outlook for the company's future.
Arya Sciences Acquisition Corp Iv

Arya Sciences Acquisition Corp IV Faces Corporate Conduct Deterioration During First Quarter of 2023 Earnings Season

The earnings season for the period of January to March 31, 2023 is underway, revealing the financial results of countless companies in different industries. One of these industries is Biotechnology & Pharmaceuticals, and among the companies in this sector that have recently announced their results is Arya Sciences Acquisition Corp IV.
According to the announcement, Arya Sciences Acquisition Corp IV has reported an operating loss of -$0.968597 million for the most recent fiscal period. Although the company has not disclosed its revenue figures yet, the latest performance should be viewed in the context of the business accomplishment of the first quarter of 2022 where the company's operating loss was $-0.252722 million.









Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com